For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Galacto-oligosaccharide is a chain of galactose (monosaccharide sugar) units that are produced by the enzymatic hydrolysis of lactose. GOS's are unabsorbed by the intestines and are fermentable in the gut by bacteria.
LPI (LP Information)' newest research report, the "Galacto-oligosaccharide Industry Forecast" looks at past sales and reviews total world Galacto-oligosaccharide sales in 2022, providing a comprehensive analysis by region and market sector of projected Galacto-oligosaccharide sales for 2023 through 2029. With Galacto-oligosaccharide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Galacto-oligosaccharide industry.
This Insight Report provides a comprehensive analysis of the global Galacto-oligosaccharide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Galacto-oligosaccharide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Galacto-oligosaccharide market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Galacto-oligosaccharide and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Galacto-oligosaccharide.
The global Galacto-oligosaccharide market size is projected to grow from US$ 623.4 million in 2022 to US$ 1400.9 million in 2029; it is expected to grow at a CAGR of 1400.9 from 2023 to 2029.
FrieslandCampina is the largest manufacturer of galacto-oligosaccharide in the world which is over 40% market share. Europe is the largest manufacture area of galacto-oligosaccharide in the world which has over 40% market share. In terms of product, power form is the largest segment of galacto-oligosaccharide which over 70% market share. In terms of application, food& beverage is the largest segment of application which is over 80% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Galacto-oligosaccharide market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Liquid Form
- Powder Form
Segmentation by application
- Food & Beverage
- Dietary Supplements
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- FrieslandCampina
- Yakult
- Ingredion
- Nissin Sugar
- Kerry
- New Francisco Biotechnology
- Quantum Hi-Tech
- Baolingbao
Key Questions Addressed in this Report
What is the 10-year outlook for the global Galacto-oligosaccharide market?
What factors are driving Galacto-oligosaccharide market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Galacto-oligosaccharide market opportunities vary by end market size?
How does Galacto-oligosaccharide break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?